Fig. 4: WT and beta RBD and S-specific Fcγ2B and Fcγ3B differ across vaccinees who developed COVID-19 or resisted disease. | Nature Immunology

Fig. 4: WT and beta RBD and S-specific Fcγ2B and Fcγ3B differ across vaccinees who developed COVID-19 or resisted disease.

From: ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

Fig. 4

a, Dot plots showing the univariate comparisons of S- and RBD-specific antibody levels to the WT or beta S (left) or RBD (left) across the vaccinees who resisted or developed COVID-19 over the study period. Differences were defined using a Wilcoxon’s rank-sum test, and all P values were corrected for multiple comparisons using the Benjamini–Hochberg method with: ***P < 0.001; **P < 0.01; *P < 0.05. b,c, Correlation matrices depicting the Spearman’s correlations between SARS-CoV-2 WT and beta B.1.351 S-specific antibody features in vaccinated individuals who resisted (b) or developed (c) COVID-19. Significance values were corrected for multiple comparisons using the Benjamini–Hochberg method and shown as: ***P < 0.001; **P < 0.01; *P < 0.05. The lower triangle shows P values, whereas the upper triangle shows Padj values.

Source data

Back to article page